Anavrin Capital Management invests in undervalued securities with a focus on predictability and risk management. They primarily invest in publicly-traded stocks globally, but may also invest in other securities. Anavrin currently subadvises a portion of a private investment fund and may provide investment advice to separately managed accounts in the future. Client accounts are managed according to their written agreements.
Anavrin Capital Management receives management fees quarterly, typically ranging from 1-2% annually, based on the value of the account. They also receive performance-based fees or allocations annually (or more frequently), typically equal to approximately 10% annually. The specific fees are negotiated on a case-by-case basis.